Wells Fargo & Company X4 Pharmaceuticals, Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 51,755 shares of XFOR stock, worth $17,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,755

Previous 53,799 3.8%

Holding current value

$17,596

Previous $31,000 9.68%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.54 - $0.86 $1,103 - $1,757	-2,044 Reduced 3.8%	51,755 $34,000
Q2 2024 Aug 13, 2024	BUY	$0.58 - $1.47 $7,444 - $18,867	12,835 Added 31.33%	53,799 $31,000
Q1 2024 May 10, 2024	BUY	$0.72 - $1.46 $4,276 - $8,672	5,940 Added 16.96%	40,964 $56,000
Q4 2023 Feb 09, 2024	BUY	$0.61 - $0.99 $4,511 - $7,322	7,396 Added 26.77%	35,024 $29,000
Q3 2023 Nov 13, 2023	SELL	$1.03 - $2.02 $22,064 - $43,272	-21,422 Reduced 43.67%	27,628 $30,000
Q2 2023 Aug 15, 2023	BUY	$0.82 - $2.49 $39,603 - $120,259	48,297 Added 6413.94%	49,050 $95,000
Q1 2023 May 12, 2023	BUY	$0.8 - $1.22 $260 - $397	326 Added 76.35%	753 $0
Q4 2022 Feb 13, 2023	SELL	$0.69 - $2.21 $104 - $335	-152 Reduced 26.25%	427 $0
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $364 - $701	410 Added 242.6%	579 $1,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.91 $23 - $51	27 Added 19.01%	169 $0
Q1 2022 May 16, 2022	BUY	$1.48 - $2.58 $25 - $43	17 Added 13.6%	142 $0
Q3 2021 Nov 15, 2021	SELL	$4.53 - $6.45 $31 - $45	-7 Reduced 5.3%	125 $1,000
Q2 2021 Aug 16, 2021	SELL	$6.49 - $9.56 $35,351 - $52,073	-5,447 Reduced 97.63%	132 $1,000
Q1 2021 May 13, 2021	SELL	$6.63 - $10.28 $143,055 - $221,811	-21,577 Reduced 79.46%	5,579 $48,000
Q4 2020 Feb 09, 2021	BUY	$5.41 - $7.4 $75,263 - $102,948	13,912 Added 105.04%	27,156 $174,000
Q3 2020 Nov 05, 2020	SELL	$6.09 - $9.15 $25,425 - $38,201	-4,175 Reduced 23.97%	13,244 $89,000
Q2 2020 Aug 13, 2020	SELL	$7.98 - $10.44 $53,601 - $70,125	-6,717 Reduced 27.83%	17,419 $163,000
Q1 2020 May 14, 2020	BUY	$6.03 - $11.01 $145,540 - $265,737	24,136 New	24,136 $242,000

Others Institutions Holding XFOR

# of Institutions

105

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $23.3M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company X4 Pharmaceuticals, Inc Transaction History